FDA NDC Directory · JSON-LD · Markdown

Susvimo

NDC 50242-078 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameRanibizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761197
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsRANIBIZUMAB (100 mg/mL)
Marketing started20211022
Package count2

External sources

Source: openFDA. Public-domain (CC0).